Chronic obstructive pulmonary disease (COPD) remains one of the major health problems nowa days. The aim of the research was to increase the treatment efficiency for COPD group B patients by using ant i biotics, mucolytics, topical nebulizer therapy and halotherapy sessions in combination therapy. Thus, the proposed combined therapy of COPD group B patients is more advanced and rational, it improves the effectiveness f basic medical therapy by optimizing the recovery and rehabilitation process, which has a ositive effect on the improvement of the seven components of QOL, it is well tolerated nd does not cause side effects.Хронічна обструктивна хвороба легень (ХОЗЛ) залишається однією з найбільших проблем здоров’я на сьогодні. Мета...